Turkish Cargo sponsored the carriage of historical artifacts from the Topkapı and Dolmabahçe Palaces to Japan

Turkish Cargo, the air cargo brand of Turkish Airlines that provides service to 124 countries, carried 186 historical artifacts, owned by Dolmabahçe and Topkapı Palaces, to Tokyo, the capital of Japan, as the sponsor carrier, in order to be displayed at the exhibition titled as "The Ottoman Empire and Tulip Culture" held as part of the events organized for 2019 which was declared as the "Year of Turkish Culture" across Japan. More>>

Pharmapack success points to sizeable growth potential for global drug delivery and packaging in 2019

Patient-centricity, eco-friendly and smart packaging trends marked as the biggest growth drivers and innovations in 2019

Paris, 19th March 2019: The drug delivery and healthcare packaging industry is set for significant growth in 2019 as Pharmapack Europe (#pharmapackeu) – a key bellwether of industry health – welcomed a record 410 exhibiting companies and nearly 5,500 attendees from 75 countries. Europe’s biggest pharmaceutical packaging and drug delivery event (Paris Expo, Porte de Versailles, France 6-7 February, 2019) saw a diversification of innovations and new drug delivery solutions, with ‘patient-centricity’ emerging as the central theme throughout this year’s edition. More>>

Biosimilar Drug Development the analytical strategy is keyfactor for your success

Heilbronn/Dortmund March 2019: The generation of analytical data for the comparison between a biosimilar and the originator product is the initial assumption in the development of biosimilars. Achieving Biosimilarity can be a controversial and complex topic when deciding the right time point and range of analytics. More>>

Envigo launches PATHWAY an optimized safety assessment solution to enable first in human clinical trials

11 March 2019, East Millstone, N.J. – Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials. PATHWAY is designed to manage the complexity of the entire safety assessment process on behalf of the company’s pharmaceutical and biotechnology customers by integrating safety assessment study types and bioanalytical support with scientific and regulatory consulting, program design and project management. More>>

Nemeras preservative-free multidose eye dropper Novelia® approved for Santens Cosopt® for Glaucoma treatments in 29 European countries

Santen announced that the preservative free formulation Cosopt iMulti® will launch in 29 European countries in the coming months

Nemera is pleased to announce that its multidose eye dropper Novelia® has been approved for the preservative-free formulation Cosopt iMulti® (20mg/ml dorzolamide + 5mg/ml timolol eye drops, solution). More>>

Teknomeks new tall cupboards elevate hygiene levels

Hygienic furniture specialist Teknomek has introduced a new range of cupboards developed with time and risk in mind. The robust units are designed to fit into SOP and reduce cleaning times, whilst eliminating trap points where dirt and contaminants could build up. More>>

Peli BioThermal Key Speakers at CTS Europe

Peli BioThermal Key Speakers at CTS Europe

Peli BioThermal, the global name in temperature controlled packaging, will highlight the rise of reusable temperature controlled packaging as guest speakers at Clinical Trial Supply Europe, being held in Milan on March 13 – 14, 2019. More>>

PredictImmune announce issuance of new patent in the US in support of commercialisation

US patent protects PredictImmune’s intellectual property relating to methods for predicting autoimmune disease risk

PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today confirmed its latest patent grant in the US. The US patent is part of PredictImmune’s third family of intellectual property (IP) relating to methods for predicting autoimmune disease risk. This follows successful grants across the company’s first family of IP in the UK and Europe in October 2018 and Canada in January this year. More>>

Protagen Protein Services expands analytical Service Spectrum in Biosimilar Development Support

Faster, more accurate characterization of biomolecular stability using Differential Scanning Calorimetry

Heilbronn/Dortmund February 2019: The success or failure of the development of a biopharmaceutical product is also governed by protein stability. Protein stability is considered a critical parameter during manufacturing, production, formulation, long term storage, efficacy, and delivery to patients. To meet our customer demands now and in the future, PPS always invests in new analytical technique and recently added a new Differential Scanning Calorimetry (DSC) device. More>>

Biopharma Group Celebrates Its 30th Anniversary

Biopharma Group is pleased to announce its 30th anniversary as a renowned organisation offering its expertise in the fields of freeze drying and processing technologies.

Established in 1989 as Biopharma Process Systems Ltd., the company initially focused on freeze drying equipment to the pharmaceutical & biotechnology industries and fast became a leading supplier of equipment in the UK & Ireland. In 1997, Biopharma Technology Ltd. was formed to offer a freeze drying R&D consultancy and lab services, with Dr. Kevin Ward joining the team in 2000 to expand the in-house expertise, services and training courses. More>>